文献速递乳腺癌放疗放疗物理与技术

放射诱导的心脏毒性可逆吗?一项3期随机对照试验中乳腺癌患者的前瞻性评估

Is Radiation-Induced Cardiac Toxicity Reversible? Prospective Evaluation of Patients With Breast Cancer Enrolled in a Phase 3 Randomized Controlled Trial.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2022-01-25

这项3期随机对照试验的二次分析纳入181例接受辅助放疗的乳腺癌患者(左乳癌102例、右乳癌79例),中位随访127个月。左乳癌组放疗后灌注缺损显著加重但1年内改善;左乳癌组16例(17.2%)、右乳癌组4例(5.5%)发生晚期心脏事件。灌注改变与晚期心脏事件不相关,而左心室剂量体积与晚期心脏事件相关。

要点

  • 左乳癌组放疗后灌注缺损显著加重,但1年内改善。
  • 左乳癌组晚期心脏事件16例(17.2%),右乳癌组4例(5.5%)。
  • 左心室接受5 Gy和10 Gy的体积与晚期心脏事件相关。

核心结论

  • 放疗与短期灌注缺损相关,该缺损在1年内改善,且与晚期心脏事件不相关。
  • 左心室接受5 Gy和10 Gy的体积与晚期心脏事件相关。

研究设计与样本

  • 一项随机研究评估逆向计划调强放疗相较正向计划调强放疗在乳腺癌放疗毒性方面的获益。
  • 二次终点为通过单光子发射计算机断层扫描评估心脏灌注,于基线、放疗后6个月、1年、2年和5年进行。
  • 共181例接受辅助放疗的患者,其中左乳癌组102例、右乳癌组79例,中位随访127个月(范围19-160个月)。

主要发现

  • 左乳癌组放疗后灌注缺损显著加重,1年内改善。
  • 左乳癌组16例(17.2%)发生晚期心脏事件,右乳癌组4例(5.5%)发生晚期心脏事件。
  • 灌注改变与晚期心脏事件不相关,但左心室剂量体积与晚期心脏事件相关。
  • 将左心室接受5 Gy和10 Gy的体积分别维持在<42 cc和<38 cc,可使10年放疗相关晚期心脏事件风险较基线降低至<5%。

关键数值与推荐

  • 左心室接受5 Gy体积<42 cc、接受10 Gy体积<38 cc时,10年放疗相关晚期心脏事件风险较基线降低至<5%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Myocardial perfusion defects after breast radiation therapy (RT) correlate with volume of irradiated left ventricle (LV). We aimed to determine the relationship between myocardial perfusion, LV dosimetry, and grade ≥2 late cardiac events in patients with breast cancer undergoing adjuvant RT. METHODS AND MATERIALS: A randomized study evaluated the benefit of inverse-planned intensity modulated radiation therapy over forward-planned intensity modulated radiation therapy for radiation toxicity in breast cancer. A secondary endpoint was evaluating cardiac perfusion by single-photon emission computed tomography done at baseline, 6 months, 1 year, 2 years, and 5 years post-RT. We used receiver operating curve and regression analysis to identify association between perfusion, radiation dose-volumes, and the risk of late cardiac events. RESULTS: Of 181 patients who received adjuvant RT, 102 were patients with cancer in the left breast (called in this study the left-sided group) and 79 were patients with cancer in the right breast (called in this study the right-sided group). Median follow-up was 127 months (range, 19-160 months). A significant worsening of perfusion defects occurred after RT in the left-sided group, which improved by 1 year. Late cardiac events were found among 16 patients (17.2%) in the left-sided group and 4 patients (5.5%) in the right-sided group. Perfusion changes did not correlate with late cardiac events, but LV dose-volumes correlated with late cardiac events. Maintaining the LV volume receiving 5 Gy and 10 Gy to <42 cc and <38cc, respectively, can reduce the risk of radiation-related late cardiac events at 10 years to <5% over baseline. CONCLUSIONS: RT was associated with short-term perfusion defects that improved within 1 year and was not correlated with late cardiac events. The ventricular volumes receiving 5 Gy and 10 Gy were correlated with late cardiac events.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Abraham A, Sanghera KP, Gheisari F, et al. Is Radiation-Induced Cardiac Toxicity Reversible? Prospective Evaluation of Patients With Breast Cancer Enrolled in a Phase 3 Randomized Controlled Trial. Int J Radiat Oncol Biol Phys. 2022. PMID: 35085715. doi:10.1016/j.ijrobp.2022.01.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。